EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR REGIMEN VERSUS MYCOPHENOLIC ACID WITH STANDARD CALCINEURIN REGIMEN IN ASIAN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR RESULTS FROM THE SUBGROUP ANALYSIS OF TRANSFORM STUDY. Issue 3 (September 2020)